Showing results (161-170 of 170) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 170 results.
The American Review of Respiratory Disease|June 1, 1992
Lack of bronchial hyperresponsiveness to methacholine and to isocapnic dry air hyperventilation in heart/lung and double-lung transplant recipients with normal lung histology. The Paris-Sud Lung Transplant GroupP Herve, N Picard, M Le Roy Ladurie, et al.
La Nouvelle Presse Medicale|May 30, 1981
[Autologous haematopoietic stem cell transplantation. Preliminary results of a regional multicentric study (author's transl)]P Herve, A Rozenbaum, E Plouvier, et al.
Transplantation|March 9, 2000
Ganciclovir-sensitive acute graft-versus-host disease in mice receiving herpes simplex virus-thymidine kinase-expressing donor T cells in a bone marrow transplantation settingE Contassot, C Ferrand, R Angonin, et al.
Insect Molecular Biology|May 30, 2013
First screening of Aedes albopictus immunogenic salivary proteinsS Doucoure, S Cornelie, S Patramool, et al.
Cancer|July 1, 1981
A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysisJ L Binet, A Auquier, G Dighiero, et al.
The European Respiratory Journal|July 9, 2011
The association between resting and mild-to-moderate exercise pulmonary artery pressureK Whyte, S Hoette, P Herve, et al.
Experimental Hematology|January 21, 2000
Vascular smooth muscle differentiation of murine stroma: a sequential modelJ P Remy-Martin, A Marandin, B Challier, et al.
Medecine Tropicale : Revue Du Corps De Sante Colonial|January 1, 1981
[Sylvatic yellow fever in Africa recent advances and present approach (author's transl)]M Germain, M Cornet, J Mouchet, et al.
Blood|November 5, 1997
Comparison of autologous bone marrow transplantation and intensive chemotherapy as postremission therapy in adult acute myeloid leukemia. The Groupe Ouest Est Leucémies Aiguës Myéloblastiques (GOELAM)J L Harousseau, J Y Cahn, B Pignon, et al.
British Journal of Haematology|August 1, 1996
Treatment of acute myelogenous leukaemia in patients aged 50-65: idarubicin is more effective than zorubicin for remission induction and prolonged disease-free survival can be obtained using a unique consolidation course. The Goelam GroupB Pignon, F Witz, B Desablens, et al.
Pageof 17